Publications by authors named "M Auffret"
The rumen microbiome is the focus of a growing body of research, mostly based on investigation of rumen fluid samples collected once from each animal. Exploring the temporal stability of rumen microbiome profiles is imperative, as it enables evaluating the reliability of findings obtained through single-timepoint sampling. We explored the temporal stability of rumen microbiomes considering taxonomic and functional aspects across the 7-month growing-finishing phase spanning 6 timepoints.
View Article and Find Full Text PDFAims: This systematic review and meta-analysis aimed to assess the efficacy of NMDA antagonists in ASD (Autism Spectrum Disorder) on the core (communication and social interaction, repetitive behavior) and associated symptoms (irritability) of ASD, as well as their safety.
Methods: PubMed, CENTRAL, CINHAL, EMBASE, and PsycINFO databases were searched until November 2023. Two authors independently selected the studies and extracted data.
Article Synopsis
- - The study investigates how resting-state brain networks are linked to creativity using high-density electroencephalography (HD-EEG) in 90 healthy participants who completed a creative behavior inventory.
- - Researchers employed machine learning techniques to analyze brain connectivity patterns, finding significant differences in functional connectivity in the gamma frequency band related to high and low creativity levels.
- - Their predictive model demonstrated good accuracy in forecasting individual creativity scores and was validated with a separate dataset, suggesting potential biomarkers for creativity based on brain networks.
Parkinson's disease (PD) progresses with motor fluctuations emerging several years after treatment initiation. Initially managed with oral medications, these fluctuations may later necessitate device-aided therapy (DATs). Globally, various DATs options are available, including continuous subcutaneous apomorphine infusion, deep brain stimulation, levodopa-carbidopa intestinal gel, levodopa-entacapone-carbidopa intestinal gel, and subcutaneous foslevodopa/foscarbidopa infusion, each with its complexities.
View Article and Find Full Text PDF